Elmiron Eye Lawsuit News

Women Who Take Elmiron Should Follow Elmiron Eyesight Damage Lawsuits Right Here

Women who take Elmiron should know the complex science underlying hundreds of Elmiron lawsuits

Tuesday, February 8, 2022 - Thousands of women are diagnosed with interstitial cystitis (IC) a painful and life-altering chronic bladder pain every day and the first thing they seek is a medical treatment to alleviate the pain. For more than 20 years, urologists have taken the easy road and prescribed Elmiron (PPS) the only drug on the market to ease the pain. IC should not be confused with common bladder pain and should not be treated with acidic juices like cranberry which could worsen IC pain. What is most concerning is that IC bladder pain usually begins with women immediately after childbirth when the mother may be breastfeeding. The doctor and mother should be concerned that Elmiron, and the devastating side effects of causing pigmentary maculopathy, a form of night blindness, could pass through the mother's milk into the baby and damage the child's vision later in life. Janssen Pharmaceuticals, the maker of Elmiron, and parent company Johnson & Johnson are unconcerned about the transfer of Elmiron to children. The company only warns that they are unaware of any study linking a mother tasking Elmiron while breastfeeding and their child developing Elmiron vision loss. Janssen has been selling Elmiron since the 1990s but waited until July 2020 to update their website to reflect Elmiron causing a condition best described as night blindness.

Night blindness is the inability to see well at night and the inability to drive. Elmiron eye damage victims have difficulty seeing clearly during the day also as objects that are not directly in front of them may appear blurry. One woman who filed an Elmiron eye damage lawsuit alleges that she can no longer work at her outdoor job that requires traversing dangerous terrain by foot for fear of falling and potentially killing herself. Others with eye damage may not be able to continue with their job, occupation, or profession and have to live off disability income. Elmiron vision damage is believed to be permanent and irreversible. Discontinuing Elmiron will not improve the condition nor keep the pain from worsening. One study gives patients that have taken Elmiron for more than five years a 25% chance of developing life-altering macular degeneration, a condition that may have been grossly misdiagnosed in the past as being "age-related." We now suspect that many of the cases may be Elmiron-related macular degeneration.

Women that have taken Elmiron every day for over a year are filing Elmiron eye damage lawsuits. Mothers wanting to know about whether or not they are hurting their children by breastfeeding them while taking Elmiron should follow the legal battles that are occurring throughout the country. Elmiron lawsuits have been organized into multidistrict litigation (MDL) to avoid replicating administrative court proceedings thousands of times and also to get a handle on the complex science underlying the Elmiron eye damage accusations. Three ophthalmologists at the prestigious Kaiser Permanente discovered that the higher the amount of Elmiron taken, the greater the likelihood of developing eye damage. 42% of patients taking 1,500 grams or more developed eye damage, compared to only 11% who took 500 to 1,000 grams.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.